Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Asia Sejahtera Mina Tbk (AGAR) vs Trimegah Karya Pratama Tbk. (UVCR)

Asia Sejahtera Mina TbkTrading
Trimegah Karya Pratama Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Asia Sejahtera Mina Tbk dan Trimegah Karya Pratama Tbk.: Asia Sejahtera Mina Tbk diperdagangkan di Rp1.270 (kapitalisasi pasar 1,03 T, volume 24 jam 2,88 jt), sedangkan Trimegah Karya Pratama Tbk. diperdagangkan di Rp147 (kapitalisasi pasar 292,02 M, volume 24 jam 7,1 jt). Perbedaan utamanya: Asia Sejahtera Mina Tbk jauh lebih besar — sekitar 3,5× kapitalisasi pasar Trimegah Karya Pratama Tbk., dan Trimegah Karya Pratama Tbk. lebih aktif diperdagangkan (7,1 jt vs 2,88 jt). Mana yang lebih baik tergantung tujuan investasimu.

AGARUVCR
Kapitalisasi Pasar
1,03 T292,02 M
Volume
2,88 jt7,1 jt
Lot
28,79 rb71 rb
Perputaran
3,26 M1,02 M
Harga Rata-rata
1.130,91144,31
Nilai Transaksi
3,26 M1,02 M
Harga Ekuilibrium Indikatif
880146
Volume Ekuilibrium Indikatif
2,86 rb80,2 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

AGAR
Lihat detail
UVCR
Lihat detail

Tentang Asia Sejahtera Mina Tbk

PT Asia Sejahtera Mina Tbk (the Company) was established based on Notarial Deed No. 12 dated August 27, 2008 of Amelia Kasih, S.H., MKn. The parent company of the Company is PT Sinar Terang Asia Raya and the main parent entity is PT Indo Kreasi Pratama, both of which were established in Indonesia.

Selengkapnya di halaman AGAR

Tentang Trimegah Karya Pratama Tbk.

PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.

Selengkapnya di halaman UVCR